Citadel Advisors’s OS Therapies OSTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$393K Buy
+245,856
New +$403K ﹤0.01% 10770

Other funds holding OSTX

Citadel Advisors's OSTX Position: Q3 2026 in Review

Citadel Advisors opened a new position in OS Therapies (OSTX) in Q3 2026: 245,856 shares worth $393K. The stake represents ﹤0.01% of the portfolio and ranks #10770 among its holdings.

32 funds tracked by Wall St. Rank hold OSTX as of Q3 2026.

  • Citadel Advisors held 245,856 shares of OS Therapies worth $393K as of Q3 2026.
  • OS Therapies was a new Citadel Advisors position in Q3 2026.
  • OS Therapies made up ﹤0.01% of Citadel Advisors's portfolio in Q3 2026, its #10770 holding.
  • 32 funds tracked by Wall St. Rank held OS Therapies as of Q3 2026.

Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.